甲型肝炎病毒细胞膜蛋白受体2促进小鼠巨噬细胞内毒素耐受
该研究先通过GSE47783数据集(LPS刺激小鼠巨噬细胞建立的脓毒症模型与内毒素耐受模型)筛选差异基因,再用RAW264.7细胞体外复制内毒素耐受与脓毒症模型验证HAVCR2表达,最后用慢病毒shRNA敲低HAVCR2后检测极化相关基因。结果发现内毒素耐受组HAVCR2 mRNA显著高于脓毒症组(2-ΔΔCT:1.10±0.10 vs. 0.60±0.10,P<0.05);敲低HAVCR2后ARG1、CD206 mRNA显著降低,TNF-α、IL-1β mRNA显著升高(均P<0.05),NOS2无显著差异。作者认为HAVCR2参与脓毒症下游炎症因子调控及内毒素耐受形成,有望成为脓毒症新治疗靶点。
要点
- 内毒素耐受组HAVCR2 mRNA显著高于脓毒症组(2-ΔΔCT:1.10±0.10 vs. 0.60±0.10,P<0.05),蛋白水平与RT-qPCR一致。
- 敲低HAVCR2后,HAVCR2--ET组ARG1 mRNA 0.50±0.10 vs. ET组1.00±0.10、CD206 mRNA 0.73±0.10 vs. 1.00±0.10,均显著降低(均P<0.05)。
- 敲低HAVCR2后,HAVCR2--ET组TNF-α mRNA 2.20±0.10 vs. ET组1.00±0.10、IL-1β mRNA 9.00±0.10 vs. 1.00±0.10,均显著升高(均P<0.05)。
- 敲低HAVCR2后两组NOS2 mRNA表达无显著差异。
- 作者认为HAVCR2参与脓毒症下游炎症因子调控和内毒素耐受形成,有望成为脓毒症新治疗靶点。
适用人群与场景
- 实验1:GSE47783数据集,来源于脂多糖(LPS)刺激小鼠巨噬细胞建立的脓毒症模型(LPS组)和内毒素耐受模型(ET组)。
- 实验2:体外培养的小鼠巨噬细胞RAW264.7,设ET组、LPS组和PBS组。
- 实验3:慢病毒shRNA敲低HAVCR2的RAW264.7细胞(HAVCR2--ET组)及未敲低HAVCR2的对照(ET组)。
处置流程与药物剂量
- 实验2:ET组细胞先用10 μg/L LPS培养24小时,再用100 μg/L LPS培养4小时;LPS组细胞用100 μg/L LPS培养4小时;PBS组给予等体积溶剂PBS 4小时。
- 实验3:用慢病毒shRNA技术敲低RAW264.7细胞HAVCR2后再次构建ET模型(HAVCR2--ET组),并设未敲低HAVCR2的对照(ET组)。
研究设计与关键结果
- 实验1:共鉴定出1 013个差异表达基因,与LPS组比较,ET组521个基因上调、492个基因下调;这些差异基因的功能为增加生物合成、减少炎症反应;信号通路主要富集于JAK/STAT、NOD样受体、Toll样受体、TNF、HIF-1;选取ET组上调第一位的HAVCR2作为研究靶点。
- 实验2:体外实验显示,高剂量LPS刺激后HAVCR2 mRNA表达较PBS组下调;ET组HAVCR2 mRNA表达显著高于LPS组(2-ΔΔCT:1.10±0.10 vs. 0.60±0.10,P<0.05);Western blotting结果与RT-qPCR一致。
- 实验3:HAVCR2--ET组ARG1 mRNA(2-ΔΔCT:0.50±0.10 vs. 1.00±0.10)和CD206 mRNA(2-ΔΔCT:0.73±0.10 vs. 1.00±0.10)显著低于ET组,TNF-α mRNA(2-ΔΔCT:2.20±0.10 vs. 1.00±0.10)和IL-1β mRNA(2-ΔΔCT:9.00±0.10 vs. 1.00±0.10)显著高于ET组,差异均有统计学意义(均P<0.05);两组NOS2 mRNA表达差异无统计学意义。
证据类型、等级与局限
- 证据类型:基础研究(基因芯片与生物信息学分析、小鼠巨噬细胞RAW264.7体外实验、慢病毒shRNA敲低实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To screen out the potential key genes of endotoxin tolerance (ET), and to provide theoretical and experimental evidence for treatment and prognosis of sepsis.
METHODS: (1) Experiment 1 (gene chip and bioinformatics analysis): ET related data set GSE47783 was downloaded from the Gene Expression Omnibus (GEO). The data set was obtained from lipopolysaccharide (LPS) stimulated mouse macrophages to establish sepsis model (LPS group) and ET model (ET group). IDEP 0.92 software was used to screen differential expressed gene (DEG) between the two groups, analyze gene ontology (GO), and locate the main functions and signaling pathways of differential genes. The protein-protein interaction (PPI) network of DEG was constructed by the Search Tool for the Retrieval of Interacting Genes Database (STRING) to screen core genes hepatitis A virus cell membrane protein receptor 2 (HAVCR2) for following up validation study. (2) Experiment 2 (reproduction of mouse macrophage RAW264.7 model): RAW264.7 cells were cultured in vitro, the ET model (ET group, cells were cultured with 10 μg/L LPS for 24 hours and then with 100 μg/L LPS for 4 hours) and sepsis model (LPS group, cells were cultured with 100 μg/L LPS for 4 hours) were reproduced by LPS stimulation. Phosphate buffer saline (PBS) group was given equal volume of solvent PBS for 4 hours. The mRNA and protein expressions of HAVCR2 were detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) and Western blotting. (3) Experiment 3 (RAW264.7 cells transfected with HAVCR2 lentiviral vector): to further clarify whether HAVCR2 was involved in the formation of ET, after knockdown of HAVCR2 in RAW264.7 cells by lentiviral short hairpin RNA (shRNA) technology, the ET model (HAVCR2--ET group) was constructed again, and the control group (ET group) without knockdown of HAVCR2 was set up. RT-qPCR method was used to detect the mRNA expressions of macrophage polarization key proteins [arginase 1 (ARG1), CD206, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), nitric oxide synthase 2 (NOS2)] in cells.
RESULTS: (1) Experiment 1: a total of 1 013 DEG were identified, compared with LPS group, 521 genes were up-regulated and 492 genes were down-regulated in ET group. The function of these DEG was to increase biosynthesis and reduce inflammatory reaction. Signal pathways were mainly enriched in Janus kinase/signal transducers and activators of transcription (JAK/STAT), NOD like receptor, Toll-like receptor (TLR), TNF, hypoxia inducible factor-1 (HIF-1). The first up-regulated HAVCR2 in the ET group was selected as the target of the study. (2) Experiment 2: the results of in vitro experiment showed that the mRNA expression of HAVCR2 after high-dose LPS stimulation was down-regulated as compared with PBS group, and the mRNA expression of HAVCR2 in ET group was significantly higher than that in LPS group (2-ΔΔCT: 1.10±0.10 vs. 0.60±0.10, P < 0.05). The results of Western blotting were consistent with RT-qPCR results. (3) Experiment 3: the mRNA expressions of ARG1 and CD206 in HAVCR2--ET group were significantly lower than those in ET group [ARG1 mRNA (2-ΔΔCT): 0.50±0.10 vs. 1.00±0.10, CD206 (2-ΔΔCT): 0.73±0.10 vs. 1.00±0.10], and the mRNA expressions of TNF-α and IL-1β were significantly higher than those in ET group [TNF-α mRNA (2-ΔΔCT): 2.20±0.10 vs. 1.00±0.10, IL-1β mRNA (2-ΔΔCT): 9.00±0.10 vs. 1.00±0.10], with significant differences (all P < 0.05). There was no significant difference in the expression of NOS2 mRNA between the two groups.
CONCLUSIONS: HAVCR2 is involved in the regulation of inflammatory factors downstream of sepsis and the formation of ET, which is expected to become a new therapeutic target of sepsis.
参考来源
- Liu Y, Liu Y, Zhang X, et al. [Hepatitis A virus cell membrane protein receptor 2 promotes endotoxin tolerance in mouse macrophages]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34053493. doi:10.3760/cma.j.cn121430-20201106-00705
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。